Malignant Respiratory System Neoplasm — Trials

Malignant Respiratory System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,130 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,650
Recruiting: 1,433
Ph III recruiting: 179
Growth YoY: +7.6%
Industry share: 37%
Top sponsor: AstraZeneca
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,492)

clinicaltrialsPublishedShowing 701–750 of 1,254 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07413952	Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases	not yet recruiting	Phase 2	45	The First Affiliated Hospital of Guangzhou Medical UniversityOTHER	1	Feb 17, 2026	clinicaltrials
NCT07414927	A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy	not yet recruiting	Phase 1 / Phase 2	48	Shanghai Best-Link Bioscience, LLCINDUSTRY